Fusion startups trade equity for $260M in federal awards
Original: Fusion startups are giving the government shares in exchange for awards. Is it worth it?
Why This Matters
Equity-for-grant deals could reshape how startups weigh federal funding going forward.
Helion and Commonwealth Fusion Systems received $260M from the Dept. of Commerce under the CHIPS and Science Act — Helion $175M, CFS $85M — in exchange for nonvoting government shares.
The U.S. Department of Commerce awarded $260 million to two leading fusion startups last week under the CHIPS and Science Act, targeting advanced semiconductor development for reactor power and control systems. Helion took $175 million; Commonwealth Fusion Systems (CFS) received $85 million. The catch: both companies agreed to hand over nonvoting equity stakes to the federal government — a sharp departure from the nondilutive grants that previously made government funding a pure win for startup investors.
For context, the dollar amounts are modest relative to each company's war chest. CFS has raised roughly $4 billion; Helion sits at $3.2 billion in committed capital. The real significance is political: after years of cuts and minimal engagement, Washington is signaling renewed interest in commercial fusion.
Private investors have poured over $14 billion into the sector, but the Fusion Industry Association argued last year that even that isn't enough. The trade group called for a one-time $10 billion federal injection, with $5.4 billion earmarked for startups. "Other nations are moving aggressively to accelerate their commercial fusion industries," a CFS spokesperson told TechCrunch, citing China specifically. The equity-for-award structure reflects the Trump administration's push for the government to share in upside when it backs winners — a model that complicates the traditional calculus for existing investors.